Osteopontin-derived synthetic peptide SVVYGLR has potent utility in the functional regeneration of oral and maxillofacial skeletal muscles

[1]  T. Kumai.  Lissajous figures of differential electromyograms of the paired temporal and paired masseter muscles in human mastication. , 1988, Archives of oral biology.

[2]  M. Kogo,et al.  Analyses of the facilitatory effect of orexin on eating and masticatory muscle activity in rats. , 2011, Journal of neurophysiology.

[3]  H. Yatani,et al.  Synthetic osteopontin-derived peptide SVVYGLR can induce neovascularization in artificial bone marrow scaffold biomaterials. , 2007, Dental materials journal.

[4]  Yong Li,et al.  Muscle injuries and repair: current trends in research. , 2002, The Journal of bone and joint surgery. American volume.

[5]  J. Morgan,et al.  Muscle satellite cells are a functionally heterogeneous population in both somite-derived and branchiomeric muscles , 2010, Developmental biology.

[6]  T. Kumai,et al.  Statistics of differential Lissajous EMG for normal occlusion and Class II malocclusion. , 1994, American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics.

[7]  C. Rathbone,et al.  Volumetric muscle loss leads to permanent disability following extremity trauma. , 2015, Journal of rehabilitation research and development.

[8]  T. Walters,et al.  A Standardized Rat Model of Volumetric Muscle Loss Injury for the Development of Tissue Engineering Therapies , 2012, BioResearch open access.

[9]  G. Vanderstraeten,et al.  Treatment of Skeletal Muscle Injury: A Review , 2012, ISRN orthopedics.

[10]  W. Roberts,et al.  Statistical analysis of differential lissajous EMG from normal occlusion and Class III malocclusion. , 1995, The Angle orthodontist.

[11]  M. Okazaki,et al.  Osteopontin-derived peptide SVVYGLR induces angiogenesis in vivo. , 2004, Dental materials journal.

[12]  R. Guldberg,et al.  * Skeletal Myoblast-Seeded Vascularized Tissue Scaffolds in the Treatment of a Large Volumetric Muscle Defect in the Rat Biceps Femoris Muscle. , 2017, Tissue engineering. Part A.

[13]  A. R. Baker,et al.  Exploratory study on the effect of osteoactivin on muscle regeneration in a rat volumetric muscle loss model , 2017, PloS one.

[14]  A. Uchinaka,et al.  Evaluation of dermal wound healing activity of synthetic peptide SVVYGLR. , 2017, Biochemical and biophysical research communications.

[15]  A. Uchinaka,et al.  Improvement of cardiac function after implanting the osteopontin-derived peptide SVVYGLR in a hamster model of dilated cardiomyopathy. , 2015, Interactive cardiovascular and thoracic surgery.

[16]  M. Kogo,et al.  Neuropeptide-Y modulates eating patterns and masticatory muscle activity in rats , 2015, Behavioural Brain Research.

[17]  Jeff W Lichtman,et al.  Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors , 2009, Proceedings of the National Academy of Sciences.

[18]  S. Kaasa,et al.  A Prospective Study of Quality of Life in Head and Neck Cancer Patients. Part II: Longitudinal Data , 2001, The Laryngoscope.

[19]  M. Grounds,et al.  The exogenous administration of basic fibroblast growth factor to regenerating skeletal muscle in mice does not enhance the process of regeneration. , 1996, Growth factors.

[20]  A. Uchinaka,et al.  Overexpression of collagen type III in injured myocardium prevents cardiac systolic dysfunction by changing the balance of collagen distribution , 2018, The Journal of thoracic and cardiovascular surgery.

[21]  M. Sandri,et al.  Mechanisms regulating skeletal muscle growth and atrophy , 2013, The FEBS journal.

[22]  A. English,et al.  Heterogeneity among muscle precursor cells in adult skeletal muscles with differing regenerative capacities , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

[23]  A. Uchinaka,et al.  Transplantation of myoblast sheets that secrete the novel peptide SVVYGLR improves cardiac function in failing hearts. , 2013, Cardiovascular research.

[24]  M. Matsuo,et al.  Angiogenic activity of osteopontin-derived peptide SVVYGLR. , 2003, Biochemical and biophysical research communications.

[25]  A. Uchinaka,et al.  SVVYGLR motif of the thrombin-cleaved N-terminal osteopontin fragment enhances the synthesis of collagen type III in myocardial fibrosis , 2015, Molecular and Cellular Biochemistry.

[26]  A. Schilling,et al.  Current Methods for Skeletal Muscle Tissue Repair and Regeneration , 2018, BioMed research international.